» Articles » PMID: 37450104

Potential Probiotic Lactobacilli Strains Isolated from Artisanal Mexican Cocido Cheese: Evidence-based Biosafety and Probiotic Action-related Traits on in Vitro Tests

Overview
Specialty Microbiology
Date 2023 Jul 14
PMID 37450104
Authors
Affiliations
Soon will be listed here.
Abstract

The biosafety of four potentially probiotic lactobacilli strains, isolated from artisanal Mexican Cocido cheese, was assessed through in vitro tests aimed to determine (1) the antibiotic susceptibility profile by broth microdilution, (2) the transferability of antibiotic resistance determinants by filter-mating, and (3) the phenotypic and genotypic stability during serial batch sub-culture (100-day period) by evaluating physiological and probiotic features and RAPD-PCR fingerprinting. Lactobacilli strains exhibited multidrug-resistance; however, resistance determinants were not transferred in the filter-mating assay. Significant (p < 0.05) differences were observed in bacterial morphology and some functional and technological properties when strains were serially sub-cultured over 50 generations (G), compared to the initial cultures (G). Conversely, the strains did not show mucinolytic and hemolytic activities either at G or after 100 generations (G). Genetic polymorphism and genomic template instability on selected strains were detected, which suggest possible evolutionary arrangements that may occur when these bacteria are largely cultured. Our findings suggest that the assessed strains did not raise in vitro biosafety concerns; however, complementary studies are still needed to establish the safe potential applications in humans and animals.

References
1.
Cunningham M, Azcarate-Peril M, Barnard A, Benoit V, Grimaldi R, Guyonnet D . Shaping the Future of Probiotics and Prebiotics. Trends Microbiol. 2021; 29(8):667-685. DOI: 10.1016/j.tim.2021.01.003. View

2.
Martinez R, Bedani R, Saad S . Scientific evidence for health effects attributed to the consumption of probiotics and prebiotics: an update for current perspectives and future challenges. Br J Nutr. 2015; 114(12):1993-2015. DOI: 10.1017/S0007114515003864. View

3.
Doron S, Snydman D . Risk and safety of probiotics. Clin Infect Dis. 2015; 60 Suppl 2:S129-34. PMC: 4490230. DOI: 10.1093/cid/civ085. View

4.
Kato K, Funabashi N, Takaoka H, Kohno H, Kishimoto T, Nakatani Y . Lactobacillus paracasei endocarditis in a consumer of probiotics with advanced and severe bicuspid aortic valve stenosis complicated with diffuse left ventricular mid-layer fibrosis. Int J Cardiol. 2016; 224:157-161. DOI: 10.1016/j.ijcard.2016.09.002. View

5.
Sendil S, Shrimanker I, Mansoora Q, Goldman J, Nookala V . Lactobacillus rhamnosus Bacteremia in an Immunocompromised Renal Transplant Patient. Cureus. 2020; 12(2):e6887. PMC: 7058391. DOI: 10.7759/cureus.6887. View